All In MedTech

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

De Novo pathway

Device trials

2

Naming "Nerivio Migra"

MAUDE reports

0

Brand "Nerivio Migra", since 2015

PubMed studies

0

Mentioning "Nerivio Migra"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Nerivio Migra

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Nerivio Migra", any status and sponsor, newest update first.

Open in Trial Radar
  • TheranicaNot on our public-company list

    NCT03076515 · 120 participants · Start Apr 2, 2017 · Primary completion Jan 31, 2018

    Device: Nerivio Migra neurostimulation; Sham Nerivio Migra · For: Acute Migraine

    Sites: Washington D.C., District of Columbia; Albany, New York; Hartford, New York · 8 sites in all

  • TheranicaNot on our public-company list

    NCT03361423 · 296 participants · Start Dec 17, 2017 · Primary completion Nov 25, 2018

    Device: Nerivio Migra-1 active device; Nerivio Migra-1 Sham device · For: Migraine Without Aura; Migraine With Aura

    Sites: Hartford, Connecticut; Springfield, Missouri; St Louis, Missouri · 12 sites in all

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Nerivio Migra", and for the whole product code for context.

This brand

0 reports: 0 malfunction, 0 injury, 0 death

Whole product code QGT

7 reports: 3 malfunction, 3 injury, 0 death

Newest reports for this brand

No MAUDE reports name this brand.

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "Nerivio Migra"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code QGT.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.